Skip to content

Home-sampling in Partner Notification of Chlamydia

Home-sampling as a Tool in a Chlamydia Trachomatis Partner Notification Context. A Multi-centre Cluster-randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01596946
Enrollment
633
Registered
2012-05-11
Start date
2006-11-30
Completion date
2011-11-30
Last updated
2012-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chlamydia

Keywords

contact tracing, home sampling, cluster randomisation

Brief summary

Though partner notification is mandatory to perform of Chlamydia trachomatis infected individuals in Sweden, there was a 10-15% annually increase of reported cases between 1997 and 2007 indicating that partner notification may not be effective in preventing transmission. The investigators wanted to determine whether there was any difference in time between home-sampling and clinical testing as a tool of partner notification measured from eliciting of partners to date of testing.

Interventions

BEHAVIORALContact tracing mode test at clinic
BEHAVIORALSelf-sampling at home - Sent Test Kit

Sponsors

Medical Research Council of Southeast Sweden
CollaboratorOTHER_GOV
Ostergotland County Council, Sweden
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Sexual Partners to chlamydia infected index patients accepting to participate in the study.

Exclusion criteria

Index patients not living in Sweden or not speaking Swedish. * MSM. * Sexual partners living in another county or abroad.

Design outcomes

Primary

MeasureTime frameDescription
Difference in time, measured as days from the meeting between the index patient and the counsellor (i.e. the eliciting of sexually partners) until the date of C. trachomatis testing of partners60 days or more were defined as an exclusion criterionDifference in time, measured as days from the meeting between the index patient and the counsellor (i.e. the eliciting of sexually partners) until the date of C. trachomatis testing of partners, if sexual partners had attended a clinic for testing or had the opportunity of home-sampling.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026